Please select from the following list of abstracts, representing the presentations given in Kos 2007 (IWWM-4) Session 2:
Indications For Treatment And The Role Of Alkylating Agents In Waldenstrom’s Macroglobulinemia. R.A. Kyle
Role Of Purine Analogs In Front-Line Treatment Of Waldenstrom’s Macroglobulinemia. V. LeBlond
Rituximab Alone or in Combination in the Frontline Treatment of Waldenstrom’s Macroglobulinemia. D.M.Weber, S. Thomas, M. Wang, R. Alexanian
Overview In Salvage Treatment In Waldenstrom’s Macroglobulinemia. M.A. Gertz
The Role Of Autologous Transplantation In Waldenstrom’s Macroglobulinemia. A. Anagnostopoulos
Novel Agents in the Treatment of Waldenstrom’s Macroglobulinemia: Update of WMCTG Clinical Trials. S.P. Treon, J.D. Soumerai, Z.R. Hunter, C.J. Patterson, A.R. Branagan, K.O’Connor, I.M. Ghobrial on behalf of the WMCTG
